Summary
In a direct leukocyte migration test, peripheral blood leukocytes were pulsed with a high dose (2.5 and 0.5 mg/ml) of 3 M KCl extracts from 5 different colorectal tumours as well as with one 3 M KCl extract of normal colonic mucosa. Patients showing a pathological migration index (⩽0.80 and ⩾1.17), with 3 or more out of 5 tumour extracts, were considered as “positives”.
With this test mode 93% (55/59) of patients with colorectal carcinomas were reactive, irrespective of the tumour stage, while only 7% (2/27) of patients with non-malignant colorectal diseases showed a “positive” reaction. Patients with malignant and non-malignant diseases of other organs were reactive in 2–3% of cases. No “positive” reactivity was observed with leukocytes from 37 healthy volunteers. Pulsing leukocytes with the normal colonic mucosal extract, a pathological migration index was found in about 20% of colorectal cancer patients, but not in healthy volunteers.
Evaluating 10 single tumour extracts individually, reactivity of cancer patients' leukocytes ranged from 65–89% of tests, the difference being not statistically significant. Leukocytes from healthy volunteers showed a pathological migration index with the different extracts in 0–6% of tests.
With the leukocyte migration test we could not differentiate between tumours of the colon, sigma or rectum. Patients bearing tumours in any part of the large bowel showed pathological leukocyte migration with extracts of colon-, sigma- and rectum tumours. When the cross-reactivity study was extended to tumours of the gastrointestinal tract, it was found that patients with colorectal tumours were reactive, in a high percentage of tests, with extracts of gastric tumours, but gastric as well as oesophageal and pancreatic cancer patients' leukocytes only reacted occasionally with colorectal tumour extracts.
In the follow-up study, a “positive” reactivity was still found 10–14 days after surgery in 27/31 patients. After more than 2 months, the frequency of “positive” reactivity decreased to 10/70 cases. Patients with local recurrence or metastases exhibited “positive” reactivity in 6/7 cases.
Similar content being viewed by others
Abbreviations
- LMT:
-
leukocyte migration test
- LM:
-
leukocyte migration
- LMI:
-
leukocyte migration inhibition
- LME:
-
leukocyte migration enhancement
- MI:
-
migration index
References
Andersen, V., Bjerrum, O., Bendixen, G., Schiødt, T., Dissing, I.: Effect of autologous mammary tumour extracts on human leukocyte migration in vitro. Int. J. Cancer 5, 357 (1970)
Arminstead, P. R., Gowland, G.: The leukocyte adherence inhibition test in cancer of the large bowel. Brit. J. Cancer 32, 568–573 (1975)
Baldwin, R. W., Embleton, M. J., Jones, J. S. P., Langham, M. J. S.: Cell-mediated and humoral immune reactions to human tumours. Int. J. Cancer 12, 73–83 (1973a)
Baldwin, R. W., Embleton, M. J., Price, M. R.: Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions. Int. J. Cancer 12, 84–92 (1973b)
Baldwin, R. W., Embleton, M. J.: Assessment of cell-mediated immunity to human tumour associated antigens. Int. Arch. Pathol. (in press)
Boodie, A. W., Jr., Urist, M. M., Chee, O. O., Holmes, E. C., Morton, D. L.: Inhibition of leukocyte migration in agarose by KCl extracts of human melanoma cell lines grown in serum free medium. Int. J. Cancer 16, 1035–1041 (1975)
Cochran, J., Spilg, W. G. S., Mackie, R. M., Thomas, C. E.: Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant diseases. Brit. Med. J. 4, 67–70 (1972)
Eckhardt, R., Heinisch, M., Meyer zum Büschenfelde, K. H.: Cellular immune reactions against common antigen, small intestine and colon antigen in patients with Crohn's disease, ulcerative colitis and cirrhosis of the liver. Scand. J. Gastroenterol. 4, 49–54 (1976)
Elias, E. G., Elias, L. L.: Autogenous leukocyte migration in human malignancies. Cancer 36, 1393–1398 (1975)
Embleton, M. J.: Significance of tumour associated antigens on human colonic carcinomata. Brit. J. Cancer 28, Suppl. I, 142–152 (1973)
Federlin, K., Maini, R. N., Russell, A. S., Dumonde, D. C.: A micromethod for peripheral leukocyte migration in tuberculin sensitivity. J. Clin. Path. 24, 533–536 (1971)
Fuks, A., Banjo, Ch., Shuster, J., Freeman, S. O., Gold, P.: Carcinoembryonic antigen (CEA): Molecular biology and clinical significance. Biochim. Biophys. Acta 417, 123–152 (1974)
Guillou, P. J., Giles, G. R.: Inhibition of leukocyte migration by tumour-associated antigens of the colon and rectum. Gut 14, 733–738 (1973)
Guillou, P. J., Brennan, T. G., Giles, G. R.: A study of human lymphnodes draining colorectal cancer using a two-stage inhibition of leukocyte migration technique. Gut 16, 290–297 (1975)
Hellström, I., Hellström, K. E., Pierce, G. E., Yang, J. P. S.: Cellular and humoral immunity to different types of human neoplasms. Nature 220, 1352–1354 (1968)
Hellström, I., Hellström, K. E., Evans, C. A., Heppner, G. H., Pierce, G. E., Yang, J. P. S.: Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor specific antigens. Proc. Nat. Acad. Sci. 62, 362–368 (1969)
Hellström, I., Hellström, K. E., Shepard, T. H.: Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut epithelium. Int. J. Cancer 6, 346–351 (1970)
Hellström, I., Hellström, K. E., Sjögren, H. O., Warner, G. A.: Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int. J. Cancer 7, 1–16 (1971a)
Hellström, I., Sjögren, H. O., Warner, G., Hellström, K. E.: Blocking of cell-mediated tumour immunity by sera from patients with growing neoplasms. Int. J. Cancer 7, 226–237 (1971b)
Herberman, R. B.: Cell-mediated immunity to tumour cells. Advanc. Cancer Res. 19, 207–263 (1974)
Hollinshead, A., Glew, D., Bunnag, B., Gold, P., Herberman, R.: Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens. Lancet I, 1191–1195 (1970)
Jones, B. M., Turnbull, A. R.: In vitro cellular immunity in mammary carcinoma. Brit. J. Cancer 29, 337–339 (1974)
Lamerz, R., Fateh-Moghadam, A.: Carcinofetale Antigene. II. Carcinoembryonales Antigen (CEA). Klin. Wochenschrift 53, 193–203 (1975)
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the folin reagent. J. Biol. Chem. 193, 265–275 (1951)
Lurie, B. B., Bull, D. M., Zamcheck, N., Steward, A. M., Helms, R. A.: Diagnosis and prognosis in colon cancer based on a profile of immune reactivity. J. Nat. Cancer Inst. 54, 319–325 (1975)
McCoy, J. L., Jerome, L. F., Dean, J. H., Cannon, G. B., Alford, T. C., Doering, T., Herberman, R. B.: Inhibition of leukocyte migration by tumour-associated antigens in soluble extracts of human breast carcinoma. J. Nat. Cancer Inst. 53, 11–17 (1974)
McCoy, J. L., Jerome, L. F., Dean, J. H., Perlin, E., Oldham, R. K., Char, D. H., Cohen, M. B., Felix, E. L., Herberman, R. B.: Inhibition of leukocyte migration by tumour-associated antigens in soluble extracts of human malignant melanoma. J. Nat. Cancer Inst. 55, 19–23 (1975)
Nairn, R. C., Nind, A. P. P., Guli, E. P. G., Davies, D. J., Rolland, J. M., McGiven, A. R., Hughes, E. S. R.: Immunological reactivity in patients with carcinoma of the colon. Brit. Med. J. 4, 706–709 (1971)
Nind, A. P. P., Matthews, N., Pihl, E. A. V., Roland, J. M., Nairn, R. C.: Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma. Brit. J. Cancer 31, 620–629 (1975)
Reisfeld, R. A., Kahan, B. D.: Biological and chemical characterization of human histocompatibility antigens. Fed. Proc. 29, 2034–2040 (1970)
Rieche, K., Arndt, A., Pasternak, G.: Cellular immunity in mammary cancer patients as measured by the leukocyte migration test (LMT). A follow-up study. Int. J. Cancer 17, 212–218 (1976)
Schultz, R. M., Woods, W. A., Chirigis, M. A.: Detection in colorectal carcinoma patients of antibody cytotoxic to established cell strains derived from carcinoma of the human colon and rectum. Int. J. Cancer 16, 16–23 (1975)
Smith, M. G. M., Dominuez, J. A., Evans, D. B., Bewick, M., Williams, R.: Changes in leukocyte migration after renal transplantation. Brit. Med. J. 275–278 (1969)
Søborg, M.: In vitro migration of peripheral human leukocytes in cellular hypersensitivity. Acta Med. Scand. 184, 135–139 (1968)
Steele, G., Sjögren, H. O., Stadenberg, I.: In vitro cell-mediated immune reactions of human melanoma and colorectal carcinoma patients demonstrated by long-term 51Chromium assays. Int. J. Cancer 17, 27–39 (1976)
Svejcar, J., Johanovsky, J., Pekárek, J.: Studies of the mechanism of delayed type hypersensitivity in tissue cultures. The influence of the specific antigen concentration upon the spleen cell migration in normal and sensitized guinea pigs. Z. Immunitätsforsch., Allergie und klin. Immun. 131, 301–316 (1966)
Walden, P. A. M., Pentycross, C. R., Leyton, R., Browne, P., Dent, J., Vernon, P.: Leukocyte migration in response to PPD in patients with trophoblastic tumours. Eur. J. Cancer 12, 277–282 (1976)
Zöller, M., Matzku, S., Schulz, U.: Leukocyte migration in gastric cancer detection: An approach towards improved specificity and sensitivity. J. Nat. Cancer Inst. 58, 897–904 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zöller, M., Matzku, S. & Schulz, U. Colorectal cancer diagnosis by a direct leukocyte migration test using a panel of tumour extracts. Cancer Immunol Immunother 2, 257–265 (1977). https://doi.org/10.1007/BF00206007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00206007